1. Role of radical prostatectomy in metastatic prostate cancer: A review
   Michael J. Metcalfe et al, 2017, Urologic Oncology: Seminars and Original Investigations CrossRef
2. Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer
   Hannah Palmer et al, 2022, Biomedicines CrossRef
3. Nimotuzumab inhibits epithelial–mesenchymal transition in prostate cancer by targeting the Akt/YB‐1/AR axis
   Sheng Hu et al, 2019, IUBMB Life CrossRef
4. Limiting tumor seeding as a therapeutic approach for metastatic disease
   Asurayya Worrede et al, 2019, Pharmacology & Therapeutics CrossRef
5. Anti-Metastasis Fascin Inhibitors Decrease the Growth of Specific Subtypes of Cancers
   Yufeng Wang et al, 2020, Cancers CrossRef
6. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review)
   H�ctor Contreras et al, 2020, International Journal of Oncology CrossRef
7. Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone
   Jacqui McGovern et al, 2018, Cancers CrossRef
8. Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre‐metastatic niches
   Gagan Deep et al, 2020, Molecular Carcinogenesis CrossRef
9. Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation—dependence on GPR120
   Pei Liang et al, 2022, Prostate Cancer and Prostatic Diseases CrossRef
10. Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target
    Enrique A. Castellón et al, 2022, International Journal of Molecular Sciences CrossRef
11. Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer
    FEDERICO F. CIFUENTES et al, 2015, Oncology Reports CrossRef
12. Cytoreductive prostatectomy: what is the evidence? A systematic review
    Simone Albisinni et al, 2019, Minerva Urologica e Nefrologica CrossRef
13. Development of Zinc‐Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer
    Yue Yuan et al, 2019, Angewandte Chemie CrossRef
14. Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1
    Mohammad Khusni B. Ahmat Amin et al, 2018, Oncogene CrossRef
15. Development of Zinc‐Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer
    Yue Yuan et al, 2019, Angewandte Chemie International Edition CrossRef
16. Orthotopic and metastatic tumour models in preclinical cancer research
    Stephen M. Stribbling et al, 2024, Pharmacology & Therapeutics CrossRef
17. Role of surgery in oligometastatic prostate cancer
    Pocharapong Jenjitranant et al, 2019, Prostate International CrossRef